Scarica l'app Stockscreener
323.82
1.49%
4.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$319.08
Aprire:
$321.36
Volume 24 ore:
186.24K
Relative Volume:
0.94
Capitalizzazione di mercato:
$8.73B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-11.85
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
+6.08%
1M Prestazione:
+5.12%
6M Prestazione:
+27.96%
1 anno Prestazione:
-5.97%
Intervallo 1D:
$318.18
$326.43
Intervallo di 1 settimana:
$302.25
$328.25
Portata 52W:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
323.82 | 8.61B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Why Bio Rad Laboratories Inc. stock appeals to analystsLong Run Comfort Guide & quick comparison of popular models - ulpravda.ru
Protein engineering market is set for steady growth to reach US$ - openPR.com
What insider trading reveals about Bio Rad Laboratories Inc. stockGap Up & Safe Entry Trade Reports - ulpravda.ru
Why Bio Rad Laboratories Inc. stock is trending among retail tradersOptions Play & Daily Momentum Trading Reports - ulpravda.ru
What analyst consensus says on Bio Rad Laboratories Inc. stockJuly 2025 Final Week & Consistent Growth Equity Picks - ulpravda.ru
Is Bio Rad Laboratories Inc. stock resilient to inflationMarket Growth Report & Consistent Growth Stock Picks - ulpravda.ru
Published on: 2026-01-09 02:49:47 - ulpravda.ru
Will Bio Rad Laboratories Inc. (BUW) stock enhance shareholder valueMarket Performance Recap & Intraday High Probability Alerts - ulpravda.ru
How Bio Rad Laboratories Inc. Class B stock gains from tech spendingQuarterly Trade Report & Technical Confirmation Trade Alerts - ulpravda.ru
Published on: 2026-01-09 02:16:09 - ulpravda.ru
What margin trends mean for Bio Rad Laboratories Inc. stockWall Street Watch & AI Powered Market Trend Analysis - ulpravda.ru
Is Bio Rad Laboratories Inc. Class B stock attractive for growth fundsJuly 2025 Price Swings & Weekly High Momentum Picks - ulpravda.ru
Published on: 2026-01-08 22:32:57 - ulpravda.ru
Is Bio Rad Laboratories Inc. stock a smart buy before Fed meetingJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Can Bio Rad Laboratories Inc. stock sustain institutional interest2025 Price Momentum & High Accuracy Investment Signals - ulpravda.ru
Can Bio Rad Laboratories Inc. stock beat market expectations this quarter2025 Market WrapUp & Intraday High Probability Alerts - ulpravda.ru
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
Laboratory Supplies Market 2026 Forecast: In-Depth Industry - openPR.com
Basic Statistics in Laboratory Quality Control - Labroots
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference - BioSpace
United States In-vitro Cancer Diagnostics Market 2025 | Lead - openPR.com
Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action2026 world cup usa national team round of 16 key players pressing system group prediction insights - ulpravda.ru
Earnings Risk: Can Bio Rad Laboratories Inc stock beat market expectations this quarterJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - moha.gov.vn
Bio-Rad Laboratories, Inc. $BIO Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Helicobacter Pylori Diagnostics Market Forecast Through - openPR.com
Sample Preparation Market 2025 Forecast: In-Depth Industry - openPR.com
Boston Trust Walden Corp Invests $26.76 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Responsive Playbooks and the BIO Inflection - Stock Traders Daily
Marathon Asset Management Ltd Sells 7,893 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein A Resin Market is expected to reach US$ 4.1 billion by 2032 - openPR.com
Newborn Screening Market Assessment 2032: Segment Analysis, - openPR.com
Japan's Life Sciences Research and Clinical Applications Fuel - openPR.com
BIO (Bio-Rad Laboratories) Sale Of Property, Plant, Equipme - GuruFocus
Harbor Capital Advisors Inc. Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
United states IVD Quality Control Market expected to grow at - openPR.com
United states Molecular Quality Controls Market expected - openPR.com
Bio-Rad Laboratories Earnings Notes - Trefis
Robust Growth in Molecular Quality Control Market (2025-2032): - openPR.com
Exchange Traded Concepts LLC Buys 7,648 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Enzyme-Linked Immunosorbent Assay Market is expected to reach - openPR.com
BIO (Bio-Rad Laboratories) EV-to-OCF : 16.80 (As of Dec. 23, 2025) - GuruFocus
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO - FinancialContent
Cell Viability Assays Market Soars as Drug Discovery Demand - openPR.com
Why Bio Rad Laboratories Inc. stock attracts global investorsTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Published on: 2025-12-20 23:30:31 - Улправда
Can Bio Rad Laboratories Inc. (BUW) stock sustain margin levelsJuly 2025 PostEarnings & Risk Managed Trade Strategies - bolumsonucanavari.com
How Bio Rad Laboratories Inc. stock performs in interest rate cycles2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
Published on: 2025-12-20 08:31:22 - Улправда
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.31%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):